Brief: Atara Biotherapeutics Inc - On May 12, Jakob Dupont Resigned From The Company As Executive Vice President, Global Head Of Research And Development
12/05/2023 23:02
Atara Biotherapeutics Inc ATRA.O :
* ATARA BIOTHERAPEUTICS INC - ON MAY 12, JAKOB DUPONT
RESIGNED
FROM THE COMPANY AS EXECUTIVE VICE PRESIDENT, GLOBAL HEAD OF
RESEARCH AND DEVELOPMENT
Source text for Eikon: ID:
Further company coverage: ATRA.O
Recent news on Atara Biotherapeutics
See all newsAtara Biotherapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Atara Biotherapeutics Q2 revenue falls on deferred revenue recognition
Brief: Atara Biotherapeutics Q2 EPS USD -0.32
Atara Biotherapeutics, Inc. expected to post a loss of 31 cents a share - Earnings Preview
Brief: Atara Biotherapeutics - May Offer Up To $79.27 Million In Common Stock As Of May 12, 2026 - SEC Filing